Aemetis (NASDAQ:AMTX) Rating Increased to Hold at Wall Street Zen

Wall Street Zen upgraded shares of Aemetis (NASDAQ:AMTX) from a sell rating to a hold rating in a report released on Sunday morning.

AMTX has been the topic of a number of other reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Aemetis in a research report on Wednesday, January 21st. Loop Capital set a $1.75 price objective on Aemetis in a report on Thursday, March 12th. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $8.25.

Aemetis Price Performance

NASDAQ:AMTX opened at $2.60 on Friday. Aemetis has a 12 month low of $1.22 and a 12 month high of $3.66. The firm has a market capitalization of $173.24 million, a PE ratio of -1.95 and a beta of 2.61. The business’s fifty day moving average price is $1.65 and its 200 day moving average price is $1.90.

Aemetis (NASDAQ:AMTX) last announced its quarterly earnings results on Thursday, March 12th. The specialty chemicals company reported ($0.24) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.28) by $0.04. The business had revenue of $43.31 million for the quarter, compared to analysts’ expectations of $72.07 million. As a group, equities analysts anticipate that Aemetis will post -2.07 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of AMTX. Catalyst Funds Management Pty Ltd purchased a new position in shares of Aemetis in the 2nd quarter valued at approximately $25,000. Creative Planning purchased a new position in Aemetis in the 2nd quarter valued at $30,000. Virtu Financial LLC acquired a new position in Aemetis in the 4th quarter valued at $31,000. HRT Financial LP acquired a new position in Aemetis in the 4th quarter valued at $36,000. Finally, Centiva Capital LP purchased a new position in Aemetis during the 3rd quarter worth $39,000. 27.02% of the stock is currently owned by institutional investors and hedge funds.

About Aemetis

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.